The Injury Lawyer Directory Blog

Genetech, the pharmaceutical company that manufactures Raptiva, has just announced a voluntary recall for their psoriasis drug due to the risk of developing a rare but serious condition from taking the dangerous drug. The Raptiva recall will take effect on June 8, 2009.

Raptiva has been linked to the development of a condition called progressive multifocal leukoencephalopathy (PML), a progressive neurologic disease affecting the central nervous system. PML causes permanent impairment of neurologic functioning and in some cases leads to death. The disease usually develops in people who already have weakened immune systems before taking Raptiva.

Raptiva is a drug administered once a week by injection to adults suffering from moderate to severe plaque psoriasis. If you are currently taking Raptiva, you should contact your doctor immediately to discuss alternative treatment options.

There have already been at least three reported incidents of Raptiva patients dying after developing PML from taking the drug. It is uncertain how many other patients have been harmed.

If you have developed PML from taking Raptiva, you should consult an experienced pharmaceutical liability lawyer at once. You may be entitled to receive compensation for your injuries.

If you have a Raptiva claim in the Oklahoma City, Oklahoma area, please contact Stipe Injury Law today to schedule a consultation.